Context: Ceramides and sphingolipids have been linked to type 2 diabetes (T2D). The Ceramides and Sphingolipids as Predictors of Incident Dysglycemia (CASPID) study is designed to determine the association of plasma sphingolipids with the pathophysiology of human T2D.
Objective: A comparison of plasma sphingolipids profiles in Black and White adults with (FH+) and without (FH-) family history of T2D.